Category: Latest News

  • Urban-gro Shifts Focus to Sports Media Following Flash Merger

    Urban-gro Shifts Focus to Sports Media Following Flash Merger

    Urban-gro Inc. (NASDAQ:UGRO) has announced a strategic pivot away from its roots in controlled environment agriculture, repositioning itself as a sports, media, and experiential marketing platform after merging with Flash Sports & Media Inc.. The company finalized its acquisition of Flash on February 17, 2026, after first revealing the deal on October 14, 2025. With…

  • WW International Targets Debt Reduction with Up to $40 Million Prepayment

    WW International Targets Debt Reduction with Up to $40 Million Prepayment

    WW International Inc. (NASDAQ:WW) said it intends to allocate as much as $40 million in cash toward reducing the principal balance of its outstanding term loan, according to a company statement. The planned repayment includes two parts: between $25 million and $30 million to cover the annual cash sweep payment due on June 24, 2026,…

  • Fulcrum Therapeutics Shares Climb After Q1 Earnings Outperform Expectations

    Fulcrum Therapeutics Shares Climb After Q1 Earnings Outperform Expectations

    Fulcrum Therapeutics Inc. (NASDAQ:FULC) moved higher in pre-market trading on Monday after reporting first-quarter results that topped analyst expectations. The clinical-stage biopharmaceutical firm posted a loss of $0.25 per share for the quarter, coming in ahead of forecasts calling for a $0.30 per share loss. Net loss totaled $18.9 million for the three months ended…

  • Lakeland Financial Tops EPS Estimates but Misses on Revenue

    Lakeland Financial Tops EPS Estimates but Misses on Revenue

    Lakeland Financial Corporation (NASDAQ:LKFN) reported first-quarter results on Monday that exceeded earnings expectations but came in slightly below revenue forecasts. Adjusted earnings per share were $1.04, beating the analyst consensus of $1.01 by $0.03, while revenue totaled $69.71 million, missing estimates of $70.42 million. The stock remained unchanged in after-hours trading following the release. Net…

  • Veradermics Shares Jump 17% on Promising Hair Loss Trial Results

    Veradermics Shares Jump 17% on Promising Hair Loss Trial Results

    Veradermics Incorporated (NYSE:MANE) saw its stock rise 17% on Monday after announcing positive topline data from a Phase 2/3 clinical study of its oral hair loss treatment, VDPHL01. The trial, known as Study ’302’, included 519 participants and successfully met all primary and key secondary endpoints with statistical significance. VDPHL01, an extended-release formulation of minoxidil,…

  • HBT Financial Tops Forecasts as CNB Acquisition Lifts Performance

    HBT Financial Tops Forecasts as CNB Acquisition Lifts Performance

    HBT Financial Inc. (NASDAQ:HBT) reported first-quarter results on Monday that exceeded expectations, supported by the recent acquisition of CNB Bank Shares, with the stock rising 2.10% in pre-market trading. Adjusted earnings per share came in at $0.68, ahead of analyst forecasts of $0.62, while revenue reached $67.33 million, surpassing estimates of $66.75 million. The company…

  • Oruka Therapeutics Shares Jump on Strong Psoriasis Trial Results

    Oruka Therapeutics Shares Jump on Strong Psoriasis Trial Results

    Oruka Therapeutics Inc. (NASDAQ:ORKA) saw its shares surge 45% after releasing encouraging Week 16 data from its ongoing EVERLAST-A Phase 2a study in patients with moderate-to-severe plaque psoriasis. The trial met its primary objective, with 63.5% of patients treated with ORKA-001 achieving PASI 100 at Week 16, indicating complete skin clearance. An identical proportion also…

  • Alliance Resource Partners Shares Climb on Revenue Beat Despite Earnings Miss

    Alliance Resource Partners Shares Climb on Revenue Beat Despite Earnings Miss

    Alliance Resource Partners L.P. (NASDAQ:ARLP) posted first-quarter results on Monday that fell short of earnings expectations but came in slightly ahead on revenue, prompting a positive reaction in early trading. The stock rose 3.61% in pre-market activity following the release. The company reported adjusted earnings per share of $0.07, missing analyst forecasts of $0.34. However,…

  • AstraZeneca Gains FDA Nod for SAPHNELO At-Home Injection in Lupus Care

    AstraZeneca Gains FDA Nod for SAPHNELO At-Home Injection in Lupus Care

    AstraZeneca plc (NASDAQ:AZN) has been granted approval by the U.S. Food and Drug Administration for a new self-injection format of SAPHNELO (anifrolumab-fnia), enabling adult patients with systemic lupus erythematosus (SLE) to administer the treatment once weekly at home alongside standard therapy. The approval is based on results from the Phase III TULIP-SC trial, which found…

  • Futures Suggest Flat Start for Wall Street: Dow Jones, S&P, Nasdaq

    Futures Suggest Flat Start for Wall Street: Dow Jones, S&P, Nasdaq

    U.S. stock futures indicate a largely unchanged open on Monday, pointing to a pause in momentum after the strong gains recorded in the previous session. Investors appear cautious, with limited conviction as uncertainty persists in the Middle East following the breakdown of U.S.-Iran peace discussions over the weekend. As negotiations between Washington and Tehran enter…